According to BB Biotech
's latest financial reports the company's current revenue (TTM ) is A$0.25 Billion. In 2023 the company made a revenue of -A$0.29 Billion an increase over the revenue in the year 2022 that were of -A$0.54 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | A$0.25 B | -188.49% |
2023 | -A$0.29 Billion | -47.23% |
2022 | -A$0.54 Billion | |
2016 | -A$1.13 Billion | -215.47% |
2015 | A$0.97 B | -48.78% |
2014 | A$1.89 B | 65.66% |
2013 | A$1.14 B | 190.17% |
2012 | A$0.39 B | -356.39% |
2011 | -A$0.16 Billion | -511.91% |
2010 | A$37.39 M | -40.3% |
2009 | A$62.63 M |